RNA sequencing studies indicate that blocking TIM-3 enhances immune cell proliferation and activation, increases T-cell cytotoxicity, and enhances anti-tumor immunity by upregulating pathways involved in acetylation, cell differentiation, immune response, apoptosis, and TGF-β signaling. The gene discussed is HAVCR2; the disease is neoplasm.